SECUKINUMAB
| Source | General Schedule |
| Body System | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS > IMMUNOSUPPRESSANTS > IMMUNOSUPPRESSANTS |
|
|
|
|
| Code & Prescriber |
Medicinal Product Pack (Name, form & strength and pack size) |
Max qty packs | Max qty units | No. of repeats | DPMQ | Max Safety Net | General Patient Charge |
|---|---|---|---|---|---|---|---|
| 10425QMP | SECUKINUMAB secukinumab 150 mg/mL injection, 2 x 1 mL pen devices (PI, CMI) |
1 | 2 | 5 | $1405.40 | $31.60 | $31.60 |
| Available brands | |||||||
| Cosentyx |
SECUKINUMAB
| Source | General Schedule |
| Body System | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS > IMMUNOSUPPRESSANTS > IMMUNOSUPPRESSANTS |
|
|
|
|
| Code & Prescriber |
Medicinal Product Pack (Name, form & strength and pack size) |
Max qty packs | Max qty units | No. of repeats | DPMQ | Max Safety Net | General Patient Charge |
|---|---|---|---|---|---|---|---|
| 10494HMP | SECUKINUMAB secukinumab 150 mg/mL injection, 2 x 1 mL pen devices (PI, CMI) |
1 | 2 | 2 | $1405.40 | $31.60 | $31.60 |
| Available brands | |||||||
| Cosentyx |
SECUKINUMAB
| Source | General Schedule |
| Body System | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS > IMMUNOSUPPRESSANTS > IMMUNOSUPPRESSANTS |
|
|
|
|
| Code & Prescriber |
Medicinal Product Pack (Name, form & strength and pack size) |
Max qty packs | Max qty units | No. of repeats | DPMQ | Max Safety Net | General Patient Charge |
|---|---|---|---|---|---|---|---|
| 10910FMP | SECUKINUMAB secukinumab 150 mg/mL injection, 2 x 1 mL pen devices (PI, CMI) |
4 | 8 | 0 | $5429.20 | $31.60 | $31.60 |
| Available brands | |||||||
| Cosentyx |
IXEKIZUMAB
| Source | General Schedule |
| Body System | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS > IMMUNOSUPPRESSANTS > IMMUNOSUPPRESSANTS |
|
|
|
|
| Code & Prescriber |
Medicinal Product Pack (Name, form & strength and pack size) |
Max qty packs | Max qty units | No. of repeats | DPMQ | Max Safety Net | General Patient Charge |
|---|---|---|---|---|---|---|---|
| 11032PMP | IXEKIZUMAB ixekizumab 80 mg/mL injection, 2 x 1 mL pen devices (PI, CMI) |
1 | 2 | 3 | $3259.93 | $31.60 | $31.60 |
| Available brands | |||||||
| Taltz |
IXEKIZUMAB
| Source | General Schedule |
| Body System | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS > IMMUNOSUPPRESSANTS > IMMUNOSUPPRESSANTS |
|
|
|
|
| Code & Prescriber |
Medicinal Product Pack (Name, form & strength and pack size) |
Max qty packs | Max qty units | No. of repeats | DPMQ | Max Safety Net | General Patient Charge |
|---|---|---|---|---|---|---|---|
| 11033QMP | IXEKIZUMAB ixekizumab 80 mg/mL injection, 2 x 1 mL pen devices (PI, CMI) |
1 | 2 | 2 | $3259.93 | $31.60 | $31.60 |
| Available brands | |||||||
| Taltz |
ETANERCEPT
| Source | General Schedule |
| Body System | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS > IMMUNOSUPPRESSANTS > IMMUNOSUPPRESSANTS |
|
|
|
|
| Code & Prescriber |
Medicinal Product Pack (Name, form & strength and pack size) |
Max qty packs | Max qty units | No. of repeats | DPMQ | Max Safety Net | General Patient Charge |
|---|---|---|---|---|---|---|---|
| 11221NMP | ETANERCEPT etanercept 50 mg/mL injection, 4 x 1 mL pen devices (PI, CMI) |
1 | 1 | 5 | $846.42 | $31.60 | $31.60 |
| Available brands | |||||||
| Brenzysa | |||||||
| Erelzia | |||||||
| Nepextoa |
ETANERCEPT
SO
Products that are in a Supply Only state will be available for dispensing, but not
for prescribing. PBS Prescriptions written prior to the Supply Only period are able
to be dispensed using either the Supply Only product where available, or an equivalent
product as specified on the PBS schedule.
Supply only until 01/10/2026
Products that are in a Supply Only state will be available for dispensing, but not
for prescribing. PBS Prescriptions written prior to the Supply Only period are able
to be dispensed using either the Supply Only product where available, or an equivalent
product as specified on the PBS schedule.
| Source | General Schedule |
| Body System | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS > IMMUNOSUPPRESSANTS > IMMUNOSUPPRESSANTS |
|
|
|
|
ETANERCEPT
SO
Products that are in a Supply Only state will be available for dispensing, but not
for prescribing. PBS Prescriptions written prior to the Supply Only period are able
to be dispensed using either the Supply Only product where available, or an equivalent
product as specified on the PBS schedule.
Supply only until 01/10/2026
Products that are in a Supply Only state will be available for dispensing, but not
for prescribing. PBS Prescriptions written prior to the Supply Only period are able
to be dispensed using either the Supply Only product where available, or an equivalent
product as specified on the PBS schedule.
| Source | General Schedule |
| Body System | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS > IMMUNOSUPPRESSANTS > IMMUNOSUPPRESSANTS |
|
|
|
|
| Code & Prescriber |
Medicinal Product Pack (Name, form & strength and pack size) |
Max qty packs | Max qty units | No. of repeats | DPMQ | Max Safety Net | General Patient Charge |
|---|---|---|---|---|---|---|---|
| 11223QMP | ETANERCEPT etanercept 25 mg injection [4 vials] (&) inert substance diluent [4 x 1 mL syringes], 1 pack (PI, CMI) |
2 | 2 | 5 | $846.44 | $31.60 | $31.60 |
| Available brands | |||||||
| Enbrel
SO
Products that are in a Supply Only state will be available for dispensing, but not
for prescribing. PBS Prescriptions written prior to the Supply Only period are able
to be dispensed using either the Supply Only product where available, or an equivalent
product as specified on the PBS schedule.
|
ETANERCEPT
SO
Products that are in a Supply Only state will be available for dispensing, but not
for prescribing. PBS Prescriptions written prior to the Supply Only period are able
to be dispensed using either the Supply Only product where available, or an equivalent
product as specified on the PBS schedule.
Supply only until 01/10/2026
Products that are in a Supply Only state will be available for dispensing, but not
for prescribing. PBS Prescriptions written prior to the Supply Only period are able
to be dispensed using either the Supply Only product where available, or an equivalent
product as specified on the PBS schedule.
| Source | General Schedule |
| Body System | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS > IMMUNOSUPPRESSANTS > IMMUNOSUPPRESSANTS |
|
|
|
|
| Code & Prescriber |
Medicinal Product Pack (Name, form & strength and pack size) |
Max qty packs | Max qty units | No. of repeats | DPMQ | Max Safety Net | General Patient Charge |
|---|---|---|---|---|---|---|---|
| 11224RMP | ETANERCEPT etanercept 50 mg/mL injection, 4 x 1 mL syringes (PI, CMI) |
1 | 1 | 5 | $846.42 | $31.60 | $31.60 |
| Available brands | |||||||
| Brenzys
SO
Products that are in a Supply Only state will be available for dispensing, but not
for prescribing. PBS Prescriptions written prior to the Supply Only period are able
to be dispensed using either the Supply Only product where available, or an equivalent
product as specified on the PBS schedule.
|
|||||||
| Enbrel
SO
Products that are in a Supply Only state will be available for dispensing, but not
for prescribing. PBS Prescriptions written prior to the Supply Only period are able
to be dispensed using either the Supply Only product where available, or an equivalent
product as specified on the PBS schedule.
|
ETANERCEPT
| Source | General Schedule |
| Body System | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS > IMMUNOSUPPRESSANTS > IMMUNOSUPPRESSANTS |
|
|
|
|
| Code & Prescriber |
Medicinal Product Pack (Name, form & strength and pack size) |
Max qty packs | Max qty units | No. of repeats | DPMQ | Max Safety Net | General Patient Charge |
|---|---|---|---|---|---|---|---|
| 11225TMP | ETANERCEPT etanercept 50 mg/mL injection, 4 x 1 mL syringes (PI, CMI) |
1 | 1 | 5 | $846.42 | $31.60 | $31.60 |
| Available brands | |||||||
| Brenzysa | |||||||
| Erelzia |
TILDRAKIZUMAB
| Source | General Schedule |
| Body System | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS > IMMUNOSUPPRESSANTS > IMMUNOSUPPRESSANTS |
|
|
|
|
| Code & Prescriber |
Medicinal Product Pack (Name, form & strength and pack size) |
Max qty packs | Max qty units | No. of repeats | DPMQ | Max Safety Net | General Patient Charge |
|---|---|---|---|---|---|---|---|
| 11613FMP | TILDRAKIZUMAB tildrakizumab 100 mg/mL injection, 1 mL syringe (PI, CMI) |
1 | 1 | 1 | $3117.48 | $31.60 | $31.60 |
| Available brands | |||||||
| Ilumya |
GUSELKUMAB
| Source | General Schedule |
| Body System | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS > IMMUNOSUPPRESSANTS > IMMUNOSUPPRESSANTS |
|
|
|
|
| Code & Prescriber |
Medicinal Product Pack (Name, form & strength and pack size) |
Max qty packs | Max qty units | No. of repeats | DPMQ | Max Safety Net | General Patient Charge |
|---|---|---|---|---|---|---|---|
| 11614GMP | GUSELKUMAB guselkumab 100 mg/mL injection, 1 x 1 mL syringe (PI, CMI) |
1 | 1 | 2 | $3615.82 | $31.60 | $31.60 |
| Available brands | |||||||
| Tremfya |
TILDRAKIZUMAB
| Source | General Schedule |
| Body System | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS > IMMUNOSUPPRESSANTS > IMMUNOSUPPRESSANTS |
|
|
|
|
| Code & Prescriber |
Medicinal Product Pack (Name, form & strength and pack size) |
Max qty packs | Max qty units | No. of repeats | DPMQ | Max Safety Net | General Patient Charge |
|---|---|---|---|---|---|---|---|
| 11616JMP | TILDRAKIZUMAB tildrakizumab 100 mg/mL injection, 1 mL syringe (PI, CMI) |
1 | 1 | 2 | $3117.48 | $31.60 | $31.60 |
| Available brands | |||||||
| Ilumya |
RISANKIZUMAB
| Source | General Schedule |
| Body System | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS > IMMUNOSUPPRESSANTS > IMMUNOSUPPRESSANTS |
|
|
|
|
| Code & Prescriber |
Medicinal Product Pack (Name, form & strength and pack size) |
Max qty packs | Max qty units | No. of repeats | DPMQ | Max Safety Net | General Patient Charge |
|---|---|---|---|---|---|---|---|
| 14111QMP | RISANKIZUMAB risankizumab 150 mg/mL injection, 1 mL pen device (PI, CMI) |
1 | 1 | 2 | $5140.26 | $31.60 | $31.60 |
| Available brands | |||||||
| Skyrizi |
RISANKIZUMAB
| Source | General Schedule |
| Body System | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS > IMMUNOSUPPRESSANTS > IMMUNOSUPPRESSANTS |
|
|
|
|
| Code & Prescriber |
Medicinal Product Pack (Name, form & strength and pack size) |
Max qty packs | Max qty units | No. of repeats | DPMQ | Max Safety Net | General Patient Charge |
|---|---|---|---|---|---|---|---|
| 14142HMP | RISANKIZUMAB risankizumab 150 mg/mL injection, 1 mL pen device (PI, CMI) |
1 | 1 | 1 | $5140.26 | $31.60 | $31.60 |
| Available brands | |||||||
| Skyrizi |
USTEKINUMAB
| Source | General Schedule |
| Body System | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS > IMMUNOSUPPRESSANTS > IMMUNOSUPPRESSANTS |
|
|
|
|
| Code & Prescriber |
Medicinal Product Pack (Name, form & strength and pack size) |
Max qty packs | Max qty units | No. of repeats | DPMQ | Max Safety Net | General Patient Charge |
|---|---|---|---|---|---|---|---|
| 14892TMP | USTEKINUMAB ustekinumab 45 mg/0.5 mL injection, 0.5 mL syringe (PI, CMI) |
1 | 1 | 2 | $789.74 | $31.60 | $31.60 |
| Available brands | |||||||
| Steqeyma |
USTEKINUMAB
| Source | General Schedule |
| Body System | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS > IMMUNOSUPPRESSANTS > IMMUNOSUPPRESSANTS |
|
|
|
|
| Code & Prescriber |
Medicinal Product Pack (Name, form & strength and pack size) |
Max qty packs | Max qty units | No. of repeats | DPMQ | Max Safety Net | General Patient Charge |
|---|---|---|---|---|---|---|---|
| 14935CMP | USTEKINUMAB ustekinumab 90 mg/mL injection, 1 mL syringe (PI, CMI) |
1 | 1 | 2 | $1002.28 | $31.60 | $31.60 |
| Available brands | |||||||
| Steqeyma |
INFLIXIMAB
| Source | S100 HSD Public |
| Body System | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS > IMMUNOSUPPRESSANTS > IMMUNOSUPPRESSANTS |
|
|
|
|
| Code & Prescriber |
Medicinal Product Pack (Name, form & strength and pack size) |
Max qty packs | Max qty units | No. of repeats | DPMQ | Max Safety Net | General Patient Charge |
|---|---|---|---|---|---|---|---|
| 5758CMP | INFLIXIMAB infliximab 100 mg injection, 1 vial (PI, CMI) |
1 | 1 | 0 | $186.16 | $31.60 | $31.60 |
| Available brands | |||||||
| Inflectraa | |||||||
| Remicadea | |||||||
| Renflexisa |
ETANERCEPT
| Source | General Schedule |
| Body System | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS > IMMUNOSUPPRESSANTS > IMMUNOSUPPRESSANTS |
|
|
|
|
| Code & Prescriber |
Medicinal Product Pack (Name, form & strength and pack size) |
Max qty packs | Max qty units | No. of repeats | DPMQ | Max Safety Net | General Patient Charge |
|---|---|---|---|---|---|---|---|
| 9037PMP | ETANERCEPT etanercept 25 mg injection [4 vials] (&) inert substance diluent [4 x 1 mL syringes], 1 pack (PI, CMI) |
2 | 2 | 3 | $846.44 | $31.60 | $31.60 |
| Available brands | |||||||
| Enbrel |
ETANERCEPT
| Source | General Schedule |
| Body System | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS > IMMUNOSUPPRESSANTS > IMMUNOSUPPRESSANTS |
|
|
|
|
| Code & Prescriber |
Medicinal Product Pack (Name, form & strength and pack size) |
Max qty packs | Max qty units | No. of repeats | DPMQ | Max Safety Net | General Patient Charge |
|---|---|---|---|---|---|---|---|
| 9091LMP | ETANERCEPT etanercept 50 mg/mL injection, 4 x 1 mL syringes (PI, CMI) |
1 | 1 | 3 | $846.42 | $31.60 | $31.60 |
| Available brands | |||||||
| Brenzysa | |||||||
| Enbrela | |||||||
| Erelzia |
USTEKINUMAB
| Source | General Schedule |
| Body System | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS > IMMUNOSUPPRESSANTS > IMMUNOSUPPRESSANTS |
|
|
|
|
| Code & Prescriber |
Medicinal Product Pack (Name, form & strength and pack size) |
Max qty packs | Max qty units | No. of repeats | DPMQ | Max Safety Net | General Patient Charge |
|---|---|---|---|---|---|---|---|
| 9304QMP | USTEKINUMAB ustekinumab 45 mg/0.5 mL injection, 0.5 mL vial (PI, CMI) |
1 | 1 | 2 | $789.74 | $31.60 | $31.60 |
| Available brands | |||||||
| Stelara |
USTEKINUMAB
| Source | General Schedule |
| Body System | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS > IMMUNOSUPPRESSANTS > IMMUNOSUPPRESSANTS |
|
|
|
|
| Code & Prescriber |
Medicinal Product Pack (Name, form & strength and pack size) |
Max qty packs | Max qty units | No. of repeats | DPMQ | Max Safety Net | General Patient Charge |
|---|---|---|---|---|---|---|---|
| 9305RMP | USTEKINUMAB ustekinumab 45 mg/0.5 mL injection, 0.5 mL vial (PI, CMI) |
1 | 1 | 1 | $789.74 | $31.60 | $31.60 |
| Available brands | |||||||
| Stelara |
ADALIMUMAB
| Source | General Schedule |
| Body System | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS > IMMUNOSUPPRESSANTS > IMMUNOSUPPRESSANTS |
|
|
|
|
| Code & Prescriber |
Medicinal Product Pack (Name, form & strength and pack size) |
Max qty packs | Max qty units | No. of repeats | DPMQ | Max Safety Net | General Patient Charge |
|---|---|---|---|---|---|---|---|
| 9425CMP | ADALIMUMAB adalimumab 40 mg/0.8 mL injection, 2 x 0.8 mL syringes (PI, CMI) |
1 | 2 | 4 | $494.12 | $31.60 | $31.60 |
| Available brands | |||||||
| Abriladaa | |||||||
| Amgevitaa | |||||||
| Hadlimaa | |||||||
| Hyrimoza |
ADALIMUMAB
| Source | General Schedule |
| Body System | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS > IMMUNOSUPPRESSANTS > IMMUNOSUPPRESSANTS |
|
|
|
|
| Code & Prescriber |
Medicinal Product Pack (Name, form & strength and pack size) |
Max qty packs | Max qty units | No. of repeats | DPMQ | Max Safety Net | General Patient Charge |
|---|---|---|---|---|---|---|---|
| 9426DMP | ADALIMUMAB adalimumab 40 mg/0.8 mL injection, 2 x 0.8 mL pen devices (PI, CMI) |
1 | 2 | 4 | $494.12 | $31.60 | $31.60 |
| Available brands | |||||||
| Abriladaa | |||||||
| Amgevitaa | |||||||
| Hadlimaa | |||||||
| Hyrimoza |
ADALIMUMAB
| Source | General Schedule |
| Body System | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS > IMMUNOSUPPRESSANTS > IMMUNOSUPPRESSANTS |
|
|
|
|
| Code & Prescriber |
Medicinal Product Pack (Name, form & strength and pack size) |
Max qty packs | Max qty units | No. of repeats | DPMQ | Max Safety Net | General Patient Charge |
|---|---|---|---|---|---|---|---|
| 9427EMP | ADALIMUMAB adalimumab 40 mg/0.8 mL injection, 2 x 0.8 mL syringes (PI, CMI) |
1 | 2 | 5 | $494.12 | $31.60 | $31.60 |
| Available brands | |||||||
| Abriladaa | |||||||
| Amgevitaa | |||||||
| Hadlimaa | |||||||
| Hyrimoza |
ADALIMUMAB
| Source | General Schedule |
| Body System | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS > IMMUNOSUPPRESSANTS > IMMUNOSUPPRESSANTS |
|
|
|
|
| Code & Prescriber |
Medicinal Product Pack (Name, form & strength and pack size) |
Max qty packs | Max qty units | No. of repeats | DPMQ | Max Safety Net | General Patient Charge |
|---|---|---|---|---|---|---|---|
| 9428FMP | ADALIMUMAB adalimumab 40 mg/0.8 mL injection, 2 x 0.8 mL pen devices (PI, CMI) |
1 | 2 | 5 | $494.12 | $31.60 | $31.60 |
| Available brands | |||||||
| Abriladaa | |||||||
| Amgevitaa | |||||||
| Hadlimaa | |||||||
| Hyrimoza |
ETANERCEPT
| Source | General Schedule |
| Body System | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS > IMMUNOSUPPRESSANTS > IMMUNOSUPPRESSANTS |
|
|
|
|
| Code & Prescriber |
Medicinal Product Pack (Name, form & strength and pack size) |
Max qty packs | Max qty units | No. of repeats | DPMQ | Max Safety Net | General Patient Charge |
|---|---|---|---|---|---|---|---|
| 9429GMP | ETANERCEPT etanercept 25 mg injection [4 vials] (&) inert substance diluent [4 x 1 mL syringes], 1 pack (PI, CMI) |
2 | 2 | 5 | $846.44 | $31.60 | $31.60 |
| Available brands | |||||||
| Enbrel |
ETANERCEPT
| Source | General Schedule |
| Body System | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS > IMMUNOSUPPRESSANTS > IMMUNOSUPPRESSANTS |
|
|
|
|
| Code & Prescriber |
Medicinal Product Pack (Name, form & strength and pack size) |
Max qty packs | Max qty units | No. of repeats | DPMQ | Max Safety Net | General Patient Charge |
|---|---|---|---|---|---|---|---|
| 9431JMP | ETANERCEPT etanercept 50 mg/mL injection, 4 x 1 mL syringes (PI, CMI) |
1 | 1 | 5 | $846.42 | $31.60 | $31.60 |
| Available brands | |||||||
| Brenzysa | |||||||
| Enbrela | |||||||
| Erelzia |
ETANERCEPT
| Source | General Schedule |
| Body System | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS > IMMUNOSUPPRESSANTS > IMMUNOSUPPRESSANTS |
|
|
|
|
| Code & Prescriber |
Medicinal Product Pack (Name, form & strength and pack size) |
Max qty packs | Max qty units | No. of repeats | DPMQ | Max Safety Net | General Patient Charge |
|---|---|---|---|---|---|---|---|
| 9461YMP | ETANERCEPT etanercept 50 mg/mL injection, 4 x 1 mL pen devices (PI, CMI) |
1 | 1 | 3 | $846.42 | $31.60 | $31.60 |
| Available brands | |||||||
| Brenzysa | |||||||
| Enbrela | |||||||
| Erelzia | |||||||
| Nepextoa |
ETANERCEPT
| Source | General Schedule |
| Body System | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS > IMMUNOSUPPRESSANTS > IMMUNOSUPPRESSANTS |
|
|
|
|
| Code & Prescriber |
Medicinal Product Pack (Name, form & strength and pack size) |
Max qty packs | Max qty units | No. of repeats | DPMQ | Max Safety Net | General Patient Charge |
|---|---|---|---|---|---|---|---|
| 9462BMP | ETANERCEPT etanercept 50 mg/mL injection, 4 x 1 mL pen devices (PI, CMI) |
1 | 1 | 5 | $846.42 | $31.60 | $31.60 |
| Available brands | |||||||
| Brenzysa | |||||||
| Enbrela | |||||||
| Erelzia | |||||||
| Nepextoa |
INFLIXIMAB
| Source | S100 HSD Private |
| Body System | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS > IMMUNOSUPPRESSANTS > IMMUNOSUPPRESSANTS |
|
|
|
|
| Code & Prescriber |
Medicinal Product Pack (Name, form & strength and pack size) |
Max qty packs | Max qty units | No. of repeats | DPMQ | Max Safety Net | General Patient Charge |
|---|---|---|---|---|---|---|---|
| 9617EMP | INFLIXIMAB infliximab 100 mg injection, 1 vial (PI, CMI) |
1 | 1 | 0 | $202.49 | $31.60 | $31.60 |
| Available brands | |||||||
| Inflectraa | |||||||
| Remicadea | |||||||
| Renflexisa |
- Legend
- aBrand equivalent a
- MPMedical Practitioner
-
SO
Supply OnlyProducts that are in a Supply Only state will be available for dispensing, but not for prescribing. PBS Prescriptions written prior to the Supply Only period are able to be dispensed using either the Supply Only product where available, or an equivalent product as specified on the PBS schedule.




